Evidence map›Paper›PMID 38895348›Full record

ArticlebioRxiv : the preprint server for biology2024

Hallmarks of tumor-experienced T cells are absent in multiple myeloma patients from diagnosis through maintenance therapy.

Carolyn Shasha, David R Glass, Ernest Moelhman, Laura Islas, Yuan Tian, Gregory L Szeto, Tao Peng, Xiaoling Song, Michelle Wurscher, Thomas F Bumol and 4 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Carolyn ShashaVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID 0000-0002-3021-9383
David R GlassVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID 0000-0001-9924-167X
Ernest MoelhmanVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Laura IslasVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Yuan TianVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Gregory L SzetoAllen Institute for Immunology, Seattle, WA, USA.ORCID 0000-0001-7604-1333
Tao PengAllen Institute for Immunology, Seattle, WA, USA.
Xiaoling SongImmunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Michelle WurscherVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Thomas F BumolAllen Institute for Immunology, Seattle, WA, USA.
Troy R TorgersonAllen Institute for Immunology, Seattle, WA, USA.
Philip D GreenbergImmunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID 0000-0003-3812-647X
Damian J GreenTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID 0000-0003-0477-1446
Evan W NewellVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID 0000-0002-2889-243X

Funding

VIRUS-MEDIATED MYELOSUPPRESSIONP01CA018029 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI STEPHANIE J LEE · 1985 to 2026
$128.4M
Transform Dissemination and Implementation Science in CTSA ProgramsUL1TR002319 · NCATS · UNIVERSITY OF WASHINGTON · PI John K. Amory · 2017 to 2026
$100.0M
NCATS NIH HHS UL1 TR002319NCI NIH HHS P01 CA018029
6 · The paper itself

Abstract

Dysregulation of the bone marrow (BM) niche in multiple myeloma (MM) alters the composition and state of resident immune cells, potentially impeding anti-tumor immunity. One common mechanism of immune inhibition in solid tumors is the induction of exhaustion in tumor-specific T cells. However, the extent of T cell tumor recognition and exhaustion is not well-characterized in MM. As the specific mechanisms of immune evasion are critical for devising effective therapeutic strategies, we deeply profiled the CD8

Identifiers

PMID38895348
PMCPMC11185627

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.